Detalhe da pesquisa
1.
The homeodomain drives favorable DNA binding energetics of prostate cancer target ONECUT2.
bioRxiv
; 2023 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37398277
2.
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.
bioRxiv
; 2023 Oct 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37905039